LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)

Alexander Stein, Lisa Paschold, Joseph Tintelnot, Eray Goekkurt, Peter Thuss‐Patience, Sylvie Lorenzen, Thomas J. Ettrich, Jorge Riera Knorrenschild, Lutz Jacobasch, Albrecht Kretzschmar, Stefan Kubicka, S-E. Al-Batran, Anke Reinacher‐Schick, Daniel Pink, M. Sinn, Udo Lindig, Axel Hinke, S. Hegewisch Becker, Mascha Binder